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Background: Different patient groups are known to use herbal remedies and conventional drugs concomitantly
(co-use). This poses a potential risk of herb-drug interaction through altering the drug’s pharmacokinetics or
pharmacodynamics. Little is known about co-use among patients in general practice. The primary aim of this study
was to compare patients in general practice that co-use herbal remedies and conventional drugs with those who
do not. The secondary aim was to register the herb-drug combinations with potential clinical relevant interactions
among the co-users.
Method: A questionnaire based cross-sectional study conducted in the autumn 2011 in a general practice office with
four general practitioners (GPs) and one intern in Western Norway. Adults >18 years who came for an office visit
were invited. The questionnaire asked about demographics, herbal use, conventional drug use and communication
about herbal use. Multivariable logistic regression was used to compare co-users to the other patients.
Results: Of the 381 patients who completed the questionnaire, the prevalence of herbal use was 44%, with bilberry
(41%), green tea (31%), garlic (27%), Aloe vera (26%) and echinacea (18%) as the most frequently used. Among those
using conventional drugs regularly, 108 (45%) co-used herbs. Close to 40% of patients on anticoagulants co-used herbs,
with garlic and bilberry as the most frequent herbs. Compared to all other patients, co-users had significantly (p < 0.05)
increased odds to be female (adjOR 2.0), age above 70 years (adjOR 3.3), use herbs to treat an illness (adjOR 4.2), use
two or more herbs (polyherbacy, adjOR 12.1) and having experienced adverse effects of herbal use (adjOR 37.5). Co-use
was also associated with use of analgesics or dermatological drugs (adjOR 5.1 and 7.9 respectively). Three out of four
patients did not discuss herbal use with any health care professional.
Conclusion: A sizable proportion of the GP patients co-used herbs with conventional drugs, also combinations
with reported interaction potential or additive effects like anticoagulants and garlic. The low disclosure of herbal
use to their GP, polyherbacy and the risk of interactions in vulnerable groups like elderly and chronically ill patients,
warrant increased awareness among GPs.
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In the last two decades there has been a considerable
increase in the herbal remedy market [1,2]. Interactions
between herbal remedies and drugs have been put on
the agenda and received increased attention [3,4]. Both
serious and less serious adverse interactions have been
reported e.g. between the drug cyclosporine and St. Johns
wort (Hypericum perforatum), and between drugs like
warfarin or aspirin which are reported to interact with
a range of herbs like garlic (Allium sativum), cranberry
(Vaccinium oxycoccos), Ginkgo Biloba, ginger (Zingiber
officinale) and grape fruit (Citrus paradisi) [5-9]. Co-use of
herbs and drugs might alter the drug’s pharmacokinetics
and/or pharmacodynamics, hence causing unexpected
adverse effects of the drug [10-13].
Studies have reported extensive use (40-56%) of herbs
in the general population [14-16]. The 2007 National
Health Interview Survey, USA, reported that nearly 20%
of the general population were using herbs [17]. The
typical herb user was female, aged 30 to 69 years, with
higher education or hospitalized in the last year [17].
Forty-one per cent of USA adults reported the use of
herbal remedies to self-treat before seeking medical care
from a physician [14].
Only 50% of herb users inform their physician about
it [14]. In addition, the health care professionals rarely
ask the patients about the use of herbs or other types
of complementary and alternative medicine [18]. ”The
doctor did not ask” is the common phrase explaining
the lack of communication [19]. The general practitioners
(GPs) also tend to underestimate the use [18]. It is
therefore important to have knowledge about the
characteristics of herb users in general and co-users in
particular to make health professionals more aware.
It is reported that up to 40% in various patient groups
co-administrate herbal remedies and drugs [20-22]. One
study found that 40% of pregnant women used herbal
remedies and about 85% of these co-used conventional
drugs [21]. The use of herbal remedies among adults
with cancer is reported to be between 30-55% [15,23]
and one study found that almost 40% co-use herbal
remedies and chemotherapy [24]. Elderly patients have
more poly-pharmacy problems and are more vulnerable
to interactions because of altered pharmacokinetics
and decreased health in general [25]. Considering that
13-47% of elderly patients report to consume herbs
[26,27] and 31- 75% of these co-use herbs and pre-
scribed conventional drugs [28,29], the risk of adverse
interactions might be high. About 50% of the general
population have one or more chronic conditions and
as the elderly, they have a high care rate and poly-
pharmacy (50%) [30]. They also tend to use more
herbal remedies, which increase the possibility of
herb-drug interactions [31].Despite the large reported use of herbs and co-use of
herbs and conventional drugs in the general population
and in various patient groups, few studies have been
performed among patients in primary care and general
practice in particular. About 40% of the patients in primary
care clinics in USA believed that taking prescription
medications and herbal remedies together was more
effective than taking either alone and nearly 50% of
the herb users co-used drugs [32]. An Israeli study on
co-use among patients in general practitioner’s offices,
reported 36% of herbal use and approximately 30%
were co-users [33]. GPs are the first medical contact
within the health care system, dealing with all health
problems both acute and chronic [34]. Given the nature of
general practice, the few studies are somewhat surprising.
The primary aim of this study was to compare patients
in a general practice in Norway that co-use herbal
remedies and drugs with those who do not, with regards
to demographics, types of drugs and herbs used, reason
for use and communication with health care professionals
about this use. The second aim was to register the
herb-drug combinations with potential clinical relevant
interactions among the co-users.Methods
This was a questionnaire based cross-sectional study.
The survey took place in a general practitioners office
with four GPs and one intern physician situated in the
city centre of a middle sized town with nearly 70 000
inhabitants on the west coast of Norway. About 6000
patients were on the GPs list at the time of the data col-
lection. The data collection took place during 5 weeks in
the autumn 2011 (11th November till 15th of December).
The study was approved by the Regional Committee for
Research Ethics in South-eastern Norway.Participants and recruitment
The inclusion criteria were patients 18 years old or older,
having an office consultation with a GP and who were
able to read and understand the questionnaire.
The questionnaire was first made available to the patients
in the waiting area for self-inclusion, but after a short time
the recruitment was done by the staff in the reception.
The reception staff was instructed to consecutively ask
the patients who contacted them when they prior or after
the GP consultation whether they would be interested
in taking part in the survey and gave the questionnaire
to those who said yes. It was not systematically registered
how many said no, but according to the staff this was
about half of the patients. The first page of the question-
naire informed the patient about the project, its objectives
and the handling of their information. In addition, in-
formation was given on wall posters in the waiting area.
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questionnaire whenever needed. The patients were asked
to return the questionnaire to the reception or by mail in
pre-addressed and pre-paid envelopes. Their answers were
anonymous. A completed questionnaire was interpreted
as informed consent.
Questionnaire
The questionnaire included questions about herbal use,
drug use and communication about herbal use and was
based on a questionnaire previously used among cancer
patients in an outpatient clinic in Central Norway [24].
The questionnaire was divided into three parts. The first
part contained questions about demographic data (Table 1)
and about conventional drugs used regularly from a
predefined list of 25 drug-categories with possibilities
to add other drugs (Table 2). The drug categories covered
most of the regularly prescribed drugs based on data
from the Norwegian Institute of Public Health and were
exemplified with common Norwegian sales name to make
them recognizable for the patients [35].
The second part asked about herbal use from a prede-
fined list of the 24 most common herbs sold in Norway
and the frequency of use [36] (Table 3). In addition,
supplements (e.g. multivitamins) and an extra space for
other herbs were also included. Only those products
defined as herbs (herbal substances, herbal preparations or
herbal medicinal products) were included in the analysis
[37]. Herb users were defined as those answering that
they used herbs daily, weekly, monthly, less than
monthly or periodically. Non-users were defined as
those answering that they do not use herbs now, but
have used herbs earlier or never used.
In the last part of the questionnaire the communication
between the patient and health care professionals,
motives for use or no use and who recommended use
of herbs were obtained (Tables 1 and 4). In addition,
they were asked about any side effects of their herbal
use and approximately monthly costs.
Statistics
To find the total number of consultations in the GP
practice during the 5 weeks data collection period, and
the age and gender distribution of these patients, a report
module of the electronic health record system was used
(WinMed 2.12r Statistics, CompuGroup Medical Norway
AS, Lysaker, Norway).
Pearson’s Chi-square was used for bivariable analyses
of categorical data, like the differences between users
and non-users of conventional drugs. In analyses that
included less than 5 cases in a cell, the Fisher exact test
was used. For multivariable analysis to disclose any as-
sociations between co-users and other variables, binary
logistic regression analysis (adjusted odds ratio, adjOR)was used. All variables with p-values <0.2 in bivariable
analysis were included in the regression analysis. In add-
ition, a separate multivariable logistic regression model
were used to compare co-users with drug-only users
including variables with a p-value <0.2 in the bivariable
analyses of variables that both co-users and drug-only
users answered (from Table 1, 2 and 3). P-values < 0.05
were considered as statistically significant. Tendencies
were ascribed for p-values between 0.05 and 0.10. The
statistics analysis was done using SPSS 19.0 (SPSS, Chicago,
IL, USA).Results
The total number of patients having consultation in the
GP office during the five weeks of data collection was
1652. Fifty-seven per cent of these were females. The
average age was 54.5 years, with 25% being 70 years old
or above. The other age groups, grouped as shown in
Table 1, were evenly distributed in the range 13-17% of
the total number patients.
Four-hundred and two questionnaires were distributed
and 381 were returned. Of the 381 respondents, 67%
were females, the average age was 52.5 years (SD = 18.11,
range 18–92) and 20% were 70 years old or above
(Table 1). About 35% had higher education and 61%
were employed or on sick leave (off sick). Nearly two
out of three (63%) used conventional drugs regularly.
Nearly half of the patients used multivitamins or sup-
plements (data not shown). A total of 164 (44%) patients
were currently using herbs, and there was a significantly
higher proportion of women using herbs compared
to men (51% of all female patients vs. 29% of all male
patients, p < 0.001, Table 1). Elderly above 70 years old,
had a significant higher herbal use with 91% using
herbs alone (herb-only user) or co-using with drugs
compared to the youngest patients (p < 0.001). A total
of 74 (20%) of the patients were using two or more
herbs (polyherbacy) and about 80% of those were
women (p < 0.001, data not shown). For the other demo-
graphic variables there was no significant differences
with regard to herb use (data not shown).
Among those using conventional drugs, 108 (45%) also
used herbs (co-users). Significant differences were seen
between the genders, age and occupational groups in
regard to co-use of drugs and herbs (Table 1). Compared
to men, females co-used significantly more drugs and
herbs (18% vs. 34%, p = 0.001). More than one of every
three patients older than 50 years were co-users and
this was significantly more than for younger patients
(p = 0.008). Those employed co-used significantly less
than those not employed (p < 0.001).
Friends or family were those most frequently recom-
mending herbal use (68%), followed by magazines or
Table 1 Demographics of all respondents according to herb and drug use; comparison of conventional and non-
conventional drug users among herbal users and non-herbal-users, and comparison of co-users with non-co-users (N = 381)
Current herbal user? Co-user
Yes No
Regular drug user? Regular drug user?






Gender Male 124 (33) 18% 11% 0.551 39% 32% 0.085 0.001B
Female 249 (65) 34% 16% 33% 16%
Age grouped <30 50 (13) 20% 20% <0.001B 18% 42% <0.001B 0.008B
30-39 58 (15) 24% 21% 24% 31%
40-49 52 (14) 12% 29% 37% 23%
50-59 65 (17) 34% 15% 34% 17%
60-69 71 (19) 38% 4% 35% 23%
>70 76 (20) 37% 7% 54% 3%
Education Compulsory 71 (19) 32% 8% 0.178 46% 13% 0.010B 0.611
Middle level 170 (45) 28% 15% 29% 27%
University 129 (34) 26% 18% 36% 20%
Employment Employed/Off sick 233 (61) 21% 20% <0.001B 30% 29% <0.001B <0.001B
Disability or
retirement pension
129 (34) 40% 5% 47% 9%
Unemployed/Home 12 (3) 58% 17% 8% 17%
Herbal use Never 152 (40) 63% 37% 0.533
Earlier 60 (16) 58% 42%
Present 164 (44) 66% 34% 0.450
Recommended to use
herbs by (n = 110):D
Friends or family 75 (68) 61% 39% 1.000
The Physician 5 (5) 80% 20% 0.647
The shop or pharmacy 32 (24) 59% 41% 0.830
Read about it in
magazines or internet
35 (6) 69% 31% 0.401
The alternative therapist 7 (32) 43% 57% 0.424
Other 3 (6) 33% 67% 0.152
Reasons for herb
use (n = 111):D
Better life expectancies 47 (3) 62% 38% 1.000
Strengthen the immune
system
79 (42) 58% 42% 0.391
Defeat an illness 18 (71) 89% 11% 0.008B
Better than nothing 7 (16) 29% 71% 0.106
Pain relief 4 (6) 50% 50% 1.000
Other 3 (4) 100% 0% 0.280
Reasons for not using
herbs (n = 177):
Never considered it 69 (3) 51% 49% 0.002B
No need/Satisfied with
the treatment I get
52 (39) 58% 42%
Do not believe in it/
seems unsafe
56 (29) 80% 20%
AP-value for comparison of conventional drug user with not conventional drug user. Analysed with Pearson Chi-Square or Fisher exact test.
Bp < 0.05.
CP-value for comparison of co-users with non-co-users. Analysed with Pearson Chi-Square or Fisher exact test.
DMultiple answers were possible.
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Significantly more of the co-users than non-co-users,
used herbs with the intention to treat an illness (89% vs11%, p = 0.008). The most common reasons for no use
were “Never considered it” (39%) and “Do not believe
in it/ Seems unsafe” (32%).
Table 2 Total number and proportion of herb users for the different drug categories (N = 239)
Drugs (ATC group) Total n (%) Proportion of co-users p-valueA
Against gastrointestinal conditions (A01-09) 15 (6) 60% 0.288
Analgesics (M01A, N02B) 55 (23) 58% 0.031B
Anti-infectives (G01, J01-05) 2 (1) 50% 1.000
Anticoagulants (B01) 88 (37) 36% 0.043B
Antidepressants (N06) 20 (8) 50% 0.815
Antidiabetics (A10) 23 (10) 52% 0.515
Antihistamines (R06) 25 (10) 32% 0.204
Antihyperlipidemic agents (C10) 81 (34) 47% 0.784
Antihypertensives and diuretics (C02-C03, C07-09) 107 (45) 45% 1.000
Anti-menopausal and anticonceptives (G01-03) 21 (9) 48% 0.823
Antirheumatic (L01, L04, M01-04) 28 (12) 39% 0.550
Antiseizure, triptanes and central stimulating drugs (N02C, N03, N06B) 20 (8) 45% 1.000
Chemotherapeutic drugs (L01-04) 5 (2) 60% 0.660
Dermal drugs (D01-11, C05) 14 (6) 64% 0.171
Drugs against urogenital and prostate disorders (G04) 11 (5) 55% 0.551
Ocular drugs (S01) 9 (4) 44% 1.000
Respiratory drugs (R01-05, 07, H02) 20 (8) 45% 1.000
Sedatives and Antipsychotics (N05) 39 (16) 49% 0.726
Strong analgesics (N02A, N07BC) 3 (1) 33% 1.000
Thyroids and antithyroids (H03) 26 (11) 54% 0.406
Vasodilators and cardiac glycosides (C01) 5 (2) 60% 0.660
Other drugs total 14 (6) 57% 0.413
AP-value for comparison of herbal user or non-user for each drug category, analysed with Pearson Chi-Square or Fisher’s exact test if the number of total users
was below five.
BSignificantly different with p < 0.05.
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myrtillus, 41%), green tea (Camelia sinensis, 31%), garlic
(Allium sativum, 27%), Aloe vera (Aloe barbadensis, 26%)
and echinacea/purple coneflower (Echinacea purpurea,
18%) were the most commonly used herbs (Table 3). For
nearly all the types of herbs used, there were no significant
difference between the types of herbs used when com-
paring those who co-used conventional drugs and those
who did not use conventional drug. Among the five
most commonly used herbs (18% or more of the users),
those who co-used conventional drugs tended to use
more Aloe vera than not conventional drug users
(p = 0.091). In addition, almost two of three (63%) of
the polyherbacy patients were also using conventional
drugs (p < 0.001).
For nearly all types of conventional drugs used there
were no significant differences between herb users and
non-users (Table 2). The only significant difference was
higher use of herbs among those using analgesics (60%
used herbs vs 40% did not, p = 0.031) or anticoagulants
(36% used herbs vs 64% did not, p = 0.043).
A total of 255 different herb-drug combinations were
registered (Additional file 1: Table S1). Of these, 18 were
identified of being at risk of clinical relevant interactions(these are highlighted with numbers in bold, Additional
file 1: Table S1). Antihypertensives and diuretics were
the largest drug categories in regard to number of com-
binations with different herbs (n = 20) followed by anal-
gesics (n = 19), antihyperlipidemic agents (n = 19) and
thyroid- or antithyroid hormones (n = 17) (Additional
file 1: Table S1). Bilberry (n = 21), green tea (n = 20) and
cranberry (n = 20) were the herbs with the highest number
of combinations with drugs. The most common combi-
nations were seen between bilberry and antihypertensives
(n = 24), anticoagulants (n = 18) or analgesics (n = 15)
(Additional file 1: Table S1). Green tea and garlic had
also high number of co-use for these drugs.
Nearly 80% of the herb users did not discuss herbal
use with any health care professional. The majority (80%)
of those were co-users (p = 0.104) (Table 4.). The most
common health care professional the patients discussed
their herbal use with was the GP (15%, data not
shown). Of those discussing herbal use with their GP,
about 80% were co-using conventional drugs (p = 0.156).
The response from the GP on disclosure of co-use differed
from encouraging continued use (32%), neutral response
(32%) and discouraged (14%) herbal use (p = 0.815, data
not shown).
Table 3 Types of herbs used and proportion of co-users






Aloe veraF 42 (26) 55% 0.091
Apple vinegar 10 (6) 70% 1.000
BilberryG 68 (41) 68% 0.740
Cranberry 26 (16) 77% 0.261
Echinacea 29 (18) 55% 0.200
Essiac 1 (1) 0% 0.341
Garlic 44 (27) 61% 0.578
Ginger 18 (11) 50% 0.186
Ginkgo Biloba 4 (2) 100% 0.300
Ginseng 15 (9) 67% 1.000
GLA/Evening Primrose oil 8 (5) 50% 0.447
Golden root 10 (6) 80% 0.497
Grapefruit 13 (8) 46% 0.135
Green tea 51 (31) 65% 0.860
Misteltoe 1 (1) 0% 0.341
Nattokinase 2 (1) 100% 0.548
Noni juice 5 (3) 20% 0.047B
Soya extract 4 (2) 75% 1.000
Valeriana 4 (2) 75% 1.000
Others in totalC 15 (9) 67% 0.480
- Other: AnthocyaninD 4 (2) 75% 1.000
- Other: Saw Palmetto 2 (1) 100% 0.548
AP-value for comparison of co- users with herb users alone. Analysed with
Pearson Chi-Square or Fisher exact test.
BSignificantly different with p < 0.05. CHerbs added by the respondent to the
open question about other herbs they used.
DAnthocyanin extracted from outer layers of bilberry and blackcurrant. EHerbs
included in the questionnaire with no users: Shark cartilage and St. Johns wort.
FMay include either topical or oral Aloe vera use.
GMay include both bilberry (V. myrtillus) and/or blueberry (V.cyanococcus) due
to confused with one another.
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herb use (data not shown), while 83% of those being
encouraged to continued use were co-users (p = 0.463).
The most common reason for no communication was “I
was never asked” (45%, p = 0.723).
All of those who had experienced adverse effects of
herbs were co-users (7%, n = 8, p = 0.020). The herbs
most frequently used by those experiencing adverse
effects were garlic (n = 5), bilberry (n = 4), green tea
(n = 4) and ginger (n = 3). The most common drugs
co-used with herbs of this group were anticoagulants
(33%) sedatives (33%) and antihypertensives (22%).
Abdominal pain, diarrhea and emesis (33%) or dizziness
(22%) was the most common reported effects.
Multivariable analysis
A total of 17 variables were included in the binary logistic
regression analysis comparing co-users to all otherpatients. Of these, seven variables were significantly
(p < 0.05) associated with co-use of herbs and con-
ventional drugs (Table 5), with an increased odds for
co-users to be female (adjOR 2.0), above 70 years (adjOR
3.3), wanting to treat an illness (adjOR 4.2), using several
herbs (polyherbacy, adjOR 12.1) and experience adverse
effects (adjOR 37.5). Increased levels of co-use were
also associated with use of analgesics or dermatological
drugs (adjOR 5.1 and 7.9 respectively). Being between
40 and 49 years old decreased the odds of being a co-user
(adjOR 0.2).
In the sub-analysis of co-user vs. drug-only users,
the model included gender, and use of anticoagulants,
analgesics and dermal drugs (data not shown). Those
who co-used drugs and herbs tended (p < 0.100) to be
female (adjOR 1.9) and use analgesics (adjOR 1.7)
compared to drug-only users.
Discussion
A total of 29% of GP patients in this study co-used herbs
and conventional drugs. The co-use was associated with
female gender, increasing age above 50 years, using
herbs to treat an illness, polyherbacy, use of analgesics
or dermatological drugs and having experienced adverse
effects from herbs.
Strengths and limitations
One of the limitations of this study was that it is a cross
sectional study, meaning that no causal relationship can
be identified. In addition, the study took place in one GP
clinic in a middle sized town on the west coast of
Norway. It thus might not be representative for other
populations, but the patients visiting the practice are
similar to other GP patients in Norway [38]. Although
those taking part in this study were representative for all
patients visiting the GP practice during the period of the
survey, those using herbs might also be more positive to
contribute to such a study than non-herb users. This
would give an overestimation in the prevalence of herb
users. However, this would also be the same for other
studies investigating herbal use, and would not hamper
the comparison with these. All data are self-reported
and inaccuracies in the reported use of herbs and drugs
must be taken into consideration. Still, the latter was
minimized by handing out lists of the most common
drugs in familiar groups with examples of the most
common sales name of the different drugs.
Herbal use
The prevalence of herbal use of 44% is somewhat higher
compared to other findings from general practice/family
doctors (22-36%) [32,33]. Our prevalence is surprisingly
close to the findings from a Norwegian cancer patient
clinic where a similar questionnaire was used (46%) [24].
Table 4 Communication with health care professionals, adverse effects and monthly costs of herbs among current
herb users and proportion of co-users of conventional drugs and herbs
Total n (%) Proportion of
co-users p-value
A
Communication about herb use with (n = 146):C PhysicianD 27 (18) 74% 0.269
Other 10 (7) 80% 0.324
Never discussed 113 (77) 59% 0.104
The health care providers response to herb
use (n = 167):
Not discussed 134 (80) 63% 0.463
Encouraged use 12 (7) 83%
Discouraged useE 7 (4) 57%
Neutral/indifferent 14 (8) 71%
Reasons for never discussing herb use
with health care professionals (n = 110):
I was never asked 50 (45) 56% 0.723
Afraid of the responseF 23 (21) 65%
Only my own concern/confidential 34 (31) 62%
Uncertain of the herbal effect 3 (3) 33%
Experienced adverse effects of herbs (n = 120)? Yes 8 (7) 100% 0.026B
No 112 (93) 61%
Costs of herb use per month (EuroG) Mean (SD, range) 36.6 (29.0, 0.4-205) 40.4 (34.8, 0.4-205) 0.337
Cost range, NOK (Euro) (n = 88) 1-199 (0.1-27.2) 24 (27) 71% 0.330
200-399 (27.3-54.5) 47 (53) 57%
400-599 (54.6-81.8) 9 (10) 56%
>600 (>82.0) 8 (9) 88%
AP-value for comparison of communication, motives for herbal use, adverse effects and costs between co-users of drugs and herbs and not co-users. Analysed
with Pearson Chi-Square or Fisher’s exact test given the number of total users were below five.
BSignificantly different with p < 0.05.
CMultiple answers were possible.
DIncludes GPs, regular GPs (family doctors) and hospital physicians.
EA merge of the responses «warned about the risk” and “discouraged use”.
FA merge of the responses “I was afraid of not getting acknowledgement for my choice”, “I was afraid they got dissatisfied” and “I was afraid of being rejected”.
GConverted from NOK to Euro. Exchange rate retrieved 23.11.2012 at 09.12 AM (1 Euro = 7.32 NOK).
Table 5 Adjusted odds ratio (adjOR) with 95% confidence intervals (95%C.l.) from multivariate regression models for




Gender Female vs male 2.0 1.0 4.0 0.043B
Age grouped Age < 30 vs: 0.000B
-30-39 0.8 0.3 2.6 0.715
-40-49 0.2 0.0 0.9 0.034B
-50-59 1.3 0.4 3.8 0.665
-60-69 2.8 1.0 8.3 0.058
->70 3.3 1.2 9.3 0.023B
Reasons for herb use Treat an illness 4.2 1.3 13.4 0.015B
Drugs Analgesics 5.1 2.4 10.7 0.000B
Dermatological drugs 7.9 2.0 30.8 0.003B
Adverse effects of the herbal remedy Yes vs No: 37.5 2.8 503.4 0.006B
Polyherbacy None or one herb vs >2 herbs: 12.1 5.8 25.4 0.000B
AP-value for multivariable logistic regression with co-use as the dependent variable. Analysed with regression analysis and Forward method in SPSS.
BSignificantly different with p < 0.05.
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eral population from other countries. The 2007 National
Health Interview Survey, USA, reported of nearly 20%
herbal use in the general population [17]. However, both
the Czech and Saudi-Arabian population reports of higher
herbal use (50-57%) compared to the USA population
[29,39]. Thus, the prevalence might vary between coun-
tries and ethnic groups [27].
Few patients were recommended herbal use by the
pharmacy or a physician. As reported by other papers,
friends or family are the common sources for herbal
recommendation or information [14,23].
Bilberry, green tea, Aloe vera, garlic and echinacea were
the most commonly used herbs among the patients.
Except from bilberry, all other herbs are also frequently
reported by others [11,17,40,41]. A sub-analysis of the
reason for using bilberry revealed that it was used largely
to strengthen the immune system (84% of bilberry user
gave this as the reason). The use of bilberry might have
been influenced by heavy marketing as a “super-food” [42].
Overall, every third patient in this study co-used drugs
and herbal remedies. Reported co-use from GP’s offices
in Israel in 2004 was lower (12%) [33], however, up-to-
date numbers from GP practice are lacking. The co-use
is in line with the co-use reported for patient groups
like pregnant women (34%) and somewhat lower than
reported for the cancer patients (30-55%) [15,21,23].
Thus, our findings are in line with earlier reported co-
use for patient groups, and the prevalence of co-use
seems to be similar across different populations.
Characteristics of co-users
Based on the high co-use of drugs and herbs, drug users
are at high risk of clinically relevant interactions [3,43]. As
expected, increasing age above 50 years was associated
with a higher co-use compared to the younger patients
in our study (nearly 40% of those >70 years old were
co-users). Earlier studies report of co-use among elderly
from 32-42% [25,44,45]. Cohen et al. found co-use of 24%
among geriatric patients, and 52% of them co-using with
anticoagulants [46]. Elderly patients are an exposed group
because of increasing poly-pharmacy, reduced general
health and altered drug metabolism [25,47]. They have
a lower tolerance for alterations in the pharmacokinet-
ics or pharmacodynamics, which might have serious
consequences [3,4,8]. In addition, females, or those taking
two or more herbs, were both significantly associated with
co-use in this study. Females are reported in several other
papers as the most common user of herbal remedies, thus
not in particular as co-users [48].
The most frequent co-use of drugs in this study was
with bilberry, green tea, garlic, Aloe vera and cranberry.
Bilberry is abounded of antioxidants and has been reported
to have anti-inflammatory activity [49]. A recent case reportindicates an interaction between bilberry and warfarin
that induces rectal bleeding [50], however, few interaction
data are published on this herb. Thus, attention should be
paid to the intake of bilberry in patients taking antiplatelet
or anticoagulant drugs. Garlic might have antiplatelet
activity and should thus, be used with care together with
antiplatelet drugs like warfarin [11,51]. Excessive bleeding
has been reported in patients co-using warfarin and
garlic, a patient group frequently using garlic [52]. Aloe
vera might cause potassium depletion or affect cardiac
glycosides and is advised not to be used together with
heart medication [11]. However, no in vitro or in vivo
pharmacological interactions have yet been established
[11,53,54]. Cranberry is reported to interact with warfarin,
increasing International Normalized ratio (INR) values by
30% [9], but an randomized controlled trial concluded
with minor risks for significant interactions in humans
[55]. Some reports state, however, that garlic, green tea,
Aloe vera and cranberry in general seem to have a low
drug interaction risk [12,55].
Those on regular analgesics or dermal drugs were sig-
nificantly associated with co-use. NSAIDs (e.g. Aspirin)
is known to interact with many herbs (e.g. ginkgo, garlic,
ginger, bilberry, ginseng) and a recent study shows
decreased in vitro metabolism of paracetamol when
co-used with Coriolus versicolor used in traditional
Chinese herbal medicine [8,56,57]. Keeping in mind
that nearly half of the co-users used two or more herbs,
the risk of interactions or additive effects are present.
In the present study, herbal adverse effects were only
reported by co-users (7%). In a recent paper from Beirut
as much as 60% of the co-users reported some sort of
adverse effects [58,59]. Although our reported prevalence
is low, those reporting adverse effects were using herbs
with reported additive effects (e.g. anticoagulants and
garlic) [11]. Still, the numbers are too low to draw any
firm conclusions.
Herb-drug interactions at risk
There were identified 255 different drug-group and
herb combinations (Additional file 1: Table S1). Of
these, 18 were identified of being at risk of clinically
relevant interactions (in bold, Additional file 1: Table S1)
on the basis of clinical trials, case reports or theoretical
interactions extrapolated from clinical data [12,60].
Anticoagulants (e.g. warfarin) were co-used with garlic
(Allium sativum), cranberry (Vaccinium oxycoccos), ginger
(Zingiber officinale), ginseng (Panax ginseng), grape
fruit juice (Citrus paradisi) and saw palmetto (Serenoa
repens), all interacting with anticoagulants increasing
the risk of adverse effects (e.g. increased haemorrhage)
[6,8,9,13,20,52].
Antihypertensives and diuretics were the largest drug
categories in regard to number of combinations with
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interaction potential with ginseng or grapefruit juice [8].
Ginseng is also reported to interact with antidiabetics,
cardiac glycosides, antidiarrheal agents and antidepres-
sants [8,60]. Co-use of garlic with NSAIDs, anti-retroviral
therapy or antidepressants have also been reported to
give clinically relevant interactions [8,60]. In general
co-use of these herbs with anticoagulants or other cardio-
vascular drugs should be discouraged or closely monitored
for adverse effects/INR [11,52]. Co-use should especially
be closely monitored or even discouraged among the
elderly [61]. Anti-constipation drugs or antidiabetic agents
should not be consumed with Aloe vera (Aloe barbadensis)
because of additive effects and the same has been
shown for valeriana (Valeriana officinalis) co-used with
antidepressants [60,62].
The duration or amount of herb use and the way of
administration of the herb (i.e. oral, topical) was not
covered in this study and would have given us more
information whether the herb-drug interaction was
clinically relevant. Aloe vera used as juice ingested
orally in large daily doses has a much higher interaction
potential contra Aloe vera used topically against skin
burns, although dermal absorption cannot be excluded.
Some of the herbs are ingested as foods like garlic and
grapefruit and will in general not be a problem, unless
used in excessive amounts.
GPs needs to ask all patients
The majority of herb users did not discuss their use of
herbs with any health care professional and only 15%
discussed herbal use with their GP. For those on con-
ventional drugs, having a chronic illness and thus having
a closer relationship to their GP, one should expect a
higher willingness to share information about their herbal
use. As the most common reason for not communicating
about the subject is “I was never asked”, there are strong
indications that patients are waiting for the GPs to be the
one to take initiative in these matters. Although there
are some characteristics of the co-users (female, elderly,
use of certain drug groups etc.), there are unfortunately
no specific variable that in our opinion can be used by
the GP to pin-point co-users. The GP should therefore
routinely ask all their patients about use of herbal remedies
in order to identify potential harmful co-use.
Conclusion
The high percentage of herbal co-use among patients
using conventional drugs in general practice, and the
relation between increasing co-use with increasing
age and comorbidity, makes general practice an arena
where co-use should be discovered. Given the under-
communication with GPs about co-use, it is difficult
to prevent unwanted adverse effects and interactions.In order to monitor co-use, all GPs should ask their
patients routinely to disclose their use of herbs.
Additional file
Additional file 1: Table S1: Concomitantly use of herbs and
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